To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MYO5BandACAA2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
555 supporting clones for gene MYO5BandACAA2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BM462048 eye, retinoblastoma .a 1 to 755 9 to 762   tiling clone, available from MGC,   754/1134
(66 %)
15 diff
(98.7 %id)
NM_001080467.2   .a 5 to 9524 1 to 9520 exact RefSeq,   9520/9520
(100 %)
0 diff
(100 %id)
CF994798 Human Placenta, placenta .a 72 to 774 28 to 730       703/731
(96 %)
9 diff
(98.8 %id)
AB290160 brain .a 188 to 9494 1 to 9310 T126A M1056L K1057M E1059K L1060E ...     9310/9310
(100 %)
5 diff
(100.0 %id)
AB032945 brain .a 278 to 9494 1 to 9220 T126A M1056L K1057M E1059K L1060E ... tiling clone, available from KIAA,   9220/9220
(100 %)
11 diff
(99.9 %id)
L29143   .a 803 to 901 1 to 99       99/99
(100 %)
0 diff
(100 %id)
BF330255 breast_normal .a 1089 to 1556 469 to 3       467/477
(97 %)
0 diff
(100 %id)
BX957106   .a 1369 to 1980 1 to 612       612/612
(100 %)
0 diff
(100 %id)
CV339931 breast .a 1567 to 1725 21 to 178       158/178
(88 %)
6 diff
(96.7 %id)
CV339929 breast .a 1614 to 2111 495 to 1     Submitted on the opposite strand 495/522
(94 %)
14 diff
(97.4 %id)
DR005228 Prostate .a 1643 to 2328 22 to 707       686/707
(97 %)
11 diff
(98.5 %id)
DB068481 testis .a 1685 to 2225 2 to 543   capped   542/542
(100 %)
2 diff
(99.7 %id)
CV339935 breast .a 1693 to 2111 420 to 1     Submitted on the opposite strand 420/421
(99 %)
5 diff
(98.9 %id)
DR003084 fetal brain .a 1885 to 2379 1 to 493       493/493
(100 %)
6 diff
(98.8 %id)
CN392865 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2005 to 2590 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
DR001769 fetal brain .a 2108 to 2715 1 to 609       609/609
(100 %)
10 diff
(98.4 %id)
BQ308241 breast .a 2126 to 2242 127 to 12       116/127
(91 %)
0 diff
(100 %id)
BQ308242 breast .a 2126 to 2236 109 to 1       109/109
(100 %)
2 diff
(98.2 %id)
BF736078 bladder_tumor .a 2362 to 2794 447 to 15     Submitted on the opposite strand 433/447
(96 %)
1 diff
(99.8 %id)
CF137719 lymph .a 2489 to 3003 1 to 521       527/521
(101 %)
10 diff
(98.1 %id)
TI_154167242   .a 2489 to 3107 79 to 698       620/761
(81 %)
19 diff
(97.6 %id)
CN392864 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2643 to 3376 9 to 741       733/741
(98 %)
7 diff
(99.1 %id)
DB229070 trachea .a 2777 to 3177 2 to 403   capped   402/406
(99 %)
2 diff
(99.6 %id)
DA770694 brain .a 2813 to 3383 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA396525 thalamus .a 2960 to 3557 2 to 599   capped   598/598
(100 %)
2 diff
(99.7 %id)
BM844087 myeloma .a 3160 to 3699 1 to 540   tiling clone,   540/540
(100 %)
0 diff
(100 %id)
CN392866 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3373 to 3889 1 to 520       520/520
(100 %)
2 diff
(99.7 %id)
AW991987 breast_normal .a 3484 to 4105 33 to 654       622/654
(95 %)
11 diff
(98.4 %id)
BE542776 cervix .a 3492 to 4217 1 to 720       720/882
(81 %)
19 diff
(97.9 %id)
BF329918 breast_normal .a 3548 to 4136 1 to 590   tiling clone,   590/591
(99 %)
5 diff
(99.2 %id)
BI003229 head_normal .a 4359 to 4800 1 to 442       442/442
(100 %)
6 diff
(98.7 %id)
CN420958 embryonic stem cells, DMSO-treated H9 cellline .a 4382 to 4710 1 to 329       329/329
(100 %)
0 diff
(100 %id)
T85008 liver and spleen .a 4514 to 4863 2 to 360       359/361
(99 %)
15 diff
(95.9 %id)
BM826357 Ascites, stomach .a 4541 to 5141 1 to 601       601/601
(100 %)
1 diff
(99.9 %id)
BE789880 large cell carcinoma, lung .a 4559 to 5222 1 to 671       669/1164
(57 %)
11 diff
(99.1 %id)
BX372101   .a 4634 to 5540 908 to 1       908/909
(99 %)
10 diff
(98.9 %id)
AW578867 colon .a 4652 to 4961 326 to 16       309/335
(92 %)
5 diff
(98.6 %id)
BF800286 colon_ins .a 4709 to 5068 362 to 1     Submitted on the opposite strand 362/363
(99 %)
12 diff
(96.7 %id)
BM853398 Ascites, stomach .a 4723 to 5263 1 to 541       541/541
(100 %)
1 diff
(99.9 %id)
EG327546 pooled .a 4774 to 5246 475 to 3     Submitted on the opposite strand 473/475
(99 %)
15 diff
(96.9 %id)
EG327508 pooled .a 4779 to 5273 496 to 1     Submitted on the opposite strand 496/496
(100 %)
16 diff
(96.8 %id)
EG327507 pooled .a 4794 to 5306 1 to 514       514/514
(100 %)
12 diff
(97.7 %id)
BU176846 eye, retinoblastoma .a 4817 to 5679 12 to 886       875/894
(97 %)
25 diff
(97.3 %id)
W40522 Pancreas, pancreatic islet .a 4827 to 5236 1 to 414       414/414
(100 %)
7 diff
(98.4 %id)
BE710459 head_neck .a 4846 to 5295 6 to 450       445/457
(97 %)
37 diff
(92.0 %id)
BG201066   .a 4898 to 5666 1 to 767       766/770
(99 %)
19 diff
(97.6 %id)
BG622637 placenta .a 4899 to 5659 1 to 763       763/766
(99 %)
11 diff
(98.6 %id)
BM703176 eye, human retina .a 4899 to 5289 1 to 391   fully sequenced,   391/391
(100 %)
1 diff
(99.8 %id)
BG183509   .a 4913 to 5605 1 to 693       693/761
(91 %)
13 diff
(98.3 %id)
BE162550 head_neck .a 4996 to 5605 1 to 600       600/706
(84 %)
28 diff
(96.1 %id)
AJ003306   .a 5021 to 5578 569 to 11       559/624
(89 %)
12 diff
(98.1 %id)
BM833617 stomach .a 5039 to 5575 1 to 536       536/536
(100 %)
2 diff
(99.7 %id)
AA402003   .a 5101 to 5202 1 to 102       102/103
(99 %)
3 diff
(97.1 %id)
TI_159714448   .a 5126 to 6051 1006 to 86   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 921/1039
(88 %)
19 diff
(98.2 %id)
BG654840 Pancreas, Purified pancreatic islet .a 5139 to 5683 1 to 551       556/551
(100 %)
7 diff
(98.8 %id)
AW373879 breast .a 5159 to 5790 637 to 6       632/637
(99 %)
4 diff
(99.4 %id)
AW373916 breast .a 5159 to 5790 637 to 6       632/637
(99 %)
4 diff
(99.4 %id)
BI518111 pooled colon, kidney, stomach .a 5176 to 5997 840 to 11   available from MGC,   830/1024
(81 %)
18 diff
(98.3 %id)
BM765200 Ascites, stomach .a 5182 to 5703 1 to 522       522/522
(100 %)
0 diff
(100 %id)
BM773145 Ascites, stomach .a 5182 to 5655 1 to 474       474/474
(100 %)
0 diff
(100 %id)
EH332743   .a 5224 to 5292 1 to 70       70/70
(100 %)
1 diff
(98.6 %id)
CB243143 Human Lung Epithelial cells, lung .a 5250 to 6050 816 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 798/798
(100 %)
4 diff
(99.5 %id)
BM664674 eye, human retina .a 5259 to 5638 399 to 20   fully sequenced, AAA   380/380
(100 %)
5 diff
(98.7 %id)
BE395529 endometrium, adenocarcinoma cell line, uterus .a 5273 to 5812 1 to 540       540/540
(100 %)
1 diff
(99.9 %id)
CV411302.
matches multiple genes
breast_normal .a 5277 to 5534 261 to 3     also hits gene LOC389740 259/263
(98 %)
8 diff
(97.0 %id)
AI991160 colon, colonic mucosa from 3 patients with Crohn'sdisease .a 5305 to 6050 742 to 1       742/742
(100 %)
14 diff
(98.2 %id)
AW194455 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 5342 to 6050 711 to 3       709/711
(99 %)
9 diff
(98.8 %id)
AW080671 colon, moderately differentiated adenocarcinoma .a 5370 to 6050 692 to 21   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 672/691
(97 %)
19 diff
(97.3 %id)
CB306880 Human Lung Epithelial cells, lung .a 5377 to 6051 693 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 675/675
(100 %)
0 diff
(100 %id)
AL577791 placenta .a 5387 to 6020 635 to 1       635/635
(100 %)
4 diff
(99.4 %id)
CB161631 Liver .a 5389 to 5964 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
H66371 liver and spleen .a 5400 to 5758 1 to 364   fully sequenced,   364/364
(100 %)
3 diff
(99.2 %id)
AA005096 liver and spleen .a 5400 to 5727 1 to 329   fully sequenced,   327/327
(100 %)
2 diff
(99.4 %id)
BF839937 head_neck .a 5403 to 5695 10 to 302       293/302
(97 %)
6 diff
(98.1 %id)
AW954511   .a 5419 to 6031 613 to 1     Submitted on the opposite strand 613/613
(100 %)
0 diff
(100 %id)
BF839941 head_neck .a 5423 to 5695 1 to 273       273/273
(100 %)
3 diff
(99.0 %id)
AW849741 colon .a 5426 to 5590 26 to 190       165/190
(86 %)
6 diff
(96.9 %id)
TI_154016937   .a 5428 to 6050 717 to 91   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 627/728
(86 %)
6 diff
(99.2 %id)
BE763883 nervous_tumor .a 5429 to 5651 227 to 5       223/228
(97 %)
10 diff
(95.7 %id)
AW996352 breast_normal .a 5430 to 5526 12 to 109       98/112
(87 %)
2 diff
(98.3 %id)
TI_149282306   .a 5457 to 6051 652 to 58   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 595/1077
(55 %)
1 diff
(100.0 %id)
AI478704 colon, moderately-differentiated adenocarcinoma .a 5464 to 6051 586 to 1       586/586
(100 %)
9 diff
(98.5 %id)
BG997229 head_neck .a 5466 to 5790 330 to 9       322/355
(90 %)
12 diff
(96.7 %id)
BM983747 lung, Primary Lung Epithelial Cells .a 5469 to 6051 601 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 583/583
(100 %)
1 diff
(99.9 %id)
AA838626 colon, colon tumor .a 5477 to 6050 574 to 1       574/574
(100 %)
21 diff
(96.4 %id)
BE044634 follicular carcinoma, thyroid .a 5477 to 6053 577 to 1       577/577
(100 %)
0 diff
(100 %id)
BI003399 head_normal .a 5479 to 5991 1 to 511       511/511
(100 %)
7 diff
(98.7 %id)
AA563940 colon, tumor .a 5484 to 6019 536 to 1       536/540
(99 %)
2 diff
(99.7 %id)
BQ189546 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 5492 to 6051 1 to 560   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 560/560
(100 %)
0 diff
(100 %id)
TI_151733870   .a 5492 to 6051 647 to 88   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 560/939
(59 %)
0 diff
(100 %id)
AA622215 Prostate, prostate tumor .a 5495 to 6019 522 to 1       522/529
(98 %)
16 diff
(97.0 %id)
AI961305 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 5511 to 6050 540 to 1       538/541
(99 %)
15 diff
(97.3 %id)
AI222470 Kidney .a 5516 to 6053 552 to 16       537/552
(97 %)
2 diff
(99.7 %id)
CA437356 lung, Metastatic Chondrosarcoma .a 5518 to 6050 552 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 534/534
(100 %)
1 diff
(99.9 %id)
BG654645 Pancreas, Purified pancreatic islet .a 5537 to 6053 521 to 5     Submitted on the opposite strand 517/521
(99 %)
0 diff
(100 %id)
BE814232 breast_normal .a 5547 to 5831 13 to 298       286/304
(94 %)
9 diff
(97.1 %id)
AI811834 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 5548 to 6053 507 to 3       505/512
(98 %)
6 diff
(98.9 %id)
BE926000 breast_normal .a 5551 to 5840 307 to 20       288/307
(93 %)
0 diff
(100 %id)
BM819540 stomach .a 5553 to 5760 208 to 1     Submitted on the opposite strand 208/208
(100 %)
0 diff
(100 %id)
AA876049 colon, colon tumor RER+ .a 5555 to 6050 496 to 1       496/496
(100 %)
2 diff
(99.6 %id)
AA773070 lung, lung carcinoma .a 5560 to 6050 492 to 2       491/492
(99 %)
0 diff
(100 %id)
AA594638 colon, colon tumor RER+ .a 5603 to 6053 457 to 7       451/460
(98 %)
0 diff
(100 %id)
AA884700 pooled .a 5621 to 6053 436 to 4       433/436
(99 %)
7 diff
(98.4 %id)
AI304604 adenocarcinoma, colon .a 5630 to 6050 421 to 1       421/421
(100 %)
0 diff
(100 %id)
BG008897 placenta_normal .a 5646 to 5773 147 to 21       127/147
(86 %)
0 diff
(100 %id)
CK300396 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 5656 to 6051 414 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 396/396
(100 %)
0 diff
(100 %id)
AA626761 lung, lung carcinoma .a 5660 to 6050 392 to 2     Submitted on the opposite strand 391/392
(99 %)
0 diff
(100 %id)
BG208075   .a 5684 to 6051 1 to 368   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 368/368
(100 %)
3 diff
(99.2 %id)
AW594703 pooled germ cell tumors .a 5685 to 5834 150 to 1       150/160
(93 %)
2 diff
(98.8 %id)
AA379458 skin .a 5686 to 6047 373 to 1     Submitted on the opposite strand 373/377
(98 %)
22 diff
(94.2 %id)
AA809699 colon .a 5687 to 5834 148 to 1       148/148
(100 %)
4 diff
(97.3 %id)
BG190592   .a 5688 to 6043 363 to 8     Submitted on the opposite strand 356/363
(98 %)
0 diff
(100 %id)
BG209683   .a 5688 to 6031 344 to 1     Submitted on the opposite strand 344/345
(99 %)
1 diff
(99.8 %id)
AI535903 Prostate .a 5691 to 6050 377 to 18   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 360/364
(98 %)
2 diff
(99.5 %id)
AA004908 liver and spleen .a 5697 to 6051 356 to 1   fully sequenced,   356/356
(100 %)
2 diff
(99.5 %id)
BF223034 pooled germ cell tumors .a 5708 to 5834 127 to 1       127/127
(100 %)
5 diff
(96.1 %id)
AA379602 skin .a 5718 to 6047 331 to 1     Submitted on the opposite strand 331/331
(100 %)
4 diff
(98.8 %id)
H66323 liver and spleen .a 5728 to 6046 338 to 1   fully sequenced,   338/338
(100 %)
16 diff
(95.3 %id)
AI535854 Prostate .a 5742 to 6008 267 to 1     Submitted on the opposite strand 267/267
(100 %)
4 diff
(98.6 %id)
CA502849 Human Lung Epithelial cells, lung .a 5744 to 5930 13 to 199     Submitted on the opposite strand 187/215
(86 %)
1 diff
(99.6 %id)
AA379305 skin .a 5768 to 6047 280 to 1     Submitted on the opposite strand 280/280
(100 %)
0 diff
(100 %id)
BF326900 breast_normal .a 5826 to 6295 480 to 11       470/480
(97 %)
0 diff
(100 %id)
AI905236 breast .a 5889 to 5962 74 to 1       74/76
(97 %)
1 diff
(98.7 %id)
DA810052 brain .a 5981 to 6540 2 to 563   capped   562/562
(100 %)
4 diff
(99.3 %id)
DB220375 trachea .a 6027 to 6592 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA018352   .a 6147 to 6655 2 to 511   capped   510/510
(100 %)
4 diff
(99.3 %id)
AJ003305   .a 6231 to 6853 628 to 6       623/628
(99 %)
0 diff
(100 %id)
EH344649   .a 6296 to 6393 1 to 98       98/98
(100 %)
1 diff
(99.0 %id)
AA456420   .a 6374 to 6685 1 to 312     Submitted on the opposite strand 312/312
(100 %)
1 diff
(99.7 %id)
AW949238 prostate_tumor .a 6557 to 6810 1 to 256       256/256
(100 %)
7 diff
(97.3 %id)
DN914550   .a 6569 to 7195 1 to 626   tiling clone,   626/626
(100 %)
4 diff
(99.4 %id)
CB266100 adipose .a 6742 to 7178 1 to 436       436/436
(100 %)
4 diff
(99.1 %id)
BX641287   .a 6788 to 7419 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
AA055336 heart .a 6896 to 7280 1 to 389     Submitted on the opposite strand 389/390
(99 %)
8 diff
(98.0 %id)
AA219282   .a 6897 to 7276 1 to 380     Submitted on the opposite strand 380/380
(100 %)
0 diff
(100 %id)
DA350416 substantia nigra .a 7540 to 8110 2 to 573   tiling clone, capped   572/572
(100 %)
1 diff
(99.9 %id)
BE612627 adenocarcinoma, ovary .a 7555 to 8296 1 to 737       737/937
(78 %)
26 diff
(97.3 %id)
CV575189 cornea, eye .a 7828 to 8410 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
F05168 brain, total brain .a 7963 to 8181 1 to 219       219/220
(99 %)
2 diff
(99.1 %id)
F05169 brain, total brain .a 7963 to 8173 1 to 211       211/211
(100 %)
1 diff
(99.6 %id)
Z41936 brain, total brain .a 7963 to 8214 1 to 252       252/252
(100 %)
1 diff
(99.7 %id)
CA773363.
matches multiple genes
Pancreas, Purified pancreatic islet .a 8011 to 8620 1 to 610     also hits gene SCG2 610/610
(100 %)
1 diff
(99.9 %id)
CA773419.
matches multiple genes
Pancreas, Purified pancreatic islet .a 8034 to 8413 1 to 381     also hits gene ZNF747andZNF768 381/381
(100 %)
14 diff
(96.4 %id)
BG434842 placenta .a 8067 to 8647 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
BQ359457 head_normal .a 8354 to 8767 583 to 170       414/607
(68 %)
0 diff
(100 %id)
CB128645 Liver .a 8429 to 9071 1 to 642       642/642
(100 %)
1 diff
(99.9 %id)
CB129072 Liver .a 8445 to 9000 1 to 556       556/556
(100 %)
2 diff
(99.7 %id)
H43358 breast .a 8490 to 9028 15 to 547       533/547
(97 %)
6 diff
(99.0 %id)
H24921 breast .a 8510 to 8846 1 to 342       342/346
(98 %)
6 diff
(98.3 %id)
BE613359 adenocarcinoma, ovary .a 8584 to 9435 835 to 1       835/835
(100 %)
23 diff
(97.3 %id)
R70680 placenta .a 8609 to 9021 1 to 418       418/421
(99 %)
21 diff
(95.1 %id)
H02371 placenta .a 8609 to 8926 1 to 322       322/446
(72 %)
6 diff
(98.7 %id)
TI_151776580   .a 8632 to 9051 80 to 505   AAA   426/1268
(33 %)
17 diff
(98.7 %id)
AA461590   .a 8801 to 9202 1 to 402   fully sequenced,   402/402
(100 %)
1 diff
(99.8 %id)
BM998401 lung, Metastatic Chondrosarcoma .a 8847 to 9494 663 to 16   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 648/648
(100 %)
1 diff
(99.9 %id)
CA773580 Pancreas, Purified pancreatic islet .a 8881 to 9493 613 to 1       613/613
(100 %)
0 diff
(100 %id)
BF805486 colon_ins .a 8888 to 9240 24 to 376       353/381
(92 %)
13 diff
(96.6 %id)
AA854156 parathyroid gland, parathyroid tumor .a 8900 to 9497 601 to 4       598/607
(98 %)
0 diff
(100 %id)
BM676161 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 8944 to 9494 566 to 16   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 551/551
(100 %)
0 diff
(100 %id)
AI468030 pooled .a 8966 to 9494 541 to 13   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 529/529
(100 %)
0 diff
(100 %id)
AI742765 pooled .a 8967 to 9493 527 to 1       527/527
(100 %)
0 diff
(100 %id)
AW300270 Kidney .a 8986 to 9497 512 to 1       512/512
(100 %)
3 diff
(99.5 %id)
AI767496 Kidney .a 9046 to 9494 450 to 1       450/450
(100 %)
1 diff
(99.8 %id)
AI979167 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 9051 to 9497 448 to 1       448/448
(100 %)
1 diff
(99.8 %id)
CB999863 Pooled-Skin .a 9061 to 9490 1 to 431       431/707
(60 %)
4 diff
(99.5 %id)
AI858931 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 9096 to 9494 399 to 1       399/399
(100 %)
2 diff
(99.5 %id)
H02272 placenta .a 9097 to 9504 424 to 1       424/424
(100 %)
23 diff
(94.6 %id)
AI492332 Kidney .a 9113 to 9496 384 to 1       384/384
(100 %)
1 diff
(99.8 %id)
R70681 placenta .a 9120 to 9513 403 to 1       403/409
(98 %)
13 diff
(96.9 %id)
H24922 breast .a 9127 to 9463 338 to 1       338/338
(100 %)
2 diff
(99.5 %id)
H92876 pineal gland .a 9160 to 9422 263 to 1       263/263
(100 %)
1 diff
(99.7 %id)
AA460302   .a 9172 to 9405 234 to 1   fully sequenced,   234/234
(100 %)
0 diff
(100 %id)
AA219466   .a 9217 to 9579 363 to 1   tiling clone, Submitted on the opposite strand 363/363
(100 %)
0 diff
(100 %id)
AI864654 pooled .a 9235 to 9497 268 to 6       263/268
(98 %)
0 diff
(100 %id)
AW052156 Kidney .a 9239 to 9494 268 to 13   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 256/256
(100 %)
3 diff
(98.9 %id)
Z38208 brain, total brain .a 9261 to 9524 264 to 1       264/264
(100 %)
0 diff
(100 %id)
F01445 brain, total brain .a 9262 to 9524 263 to 1       263/263
(100 %)
0 diff
(100 %id)
F01416 brain, total brain .a 9263 to 9524 262 to 1       262/262
(100 %)
0 diff
(100 %id)
AK025336 colon .b 1 to 3109 3 to 3110 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 3110/3110
(100 %)
2 diff
(100.0 %id)
AL133643 testis .b 364 to 3109 1 to 2745   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 2747/2745
(100 %)
1 diff
(100.0 %id)
BF760505 colon .b 1057 to 1456 21 to 420       400/420
(95 %)
10 diff
(97.7 %id)
BG169529 hypernephroma, cell line, Kidney .b 1140 to 1810 1 to 682       682/728
(93 %)
24 diff
(96.8 %id)
BE796588 lung, small cell carcinoma .b 1196 to 1411 1 to 214       214/214
(100 %)
9 diff
(95.8 %id)
AA132679 colon, tumor .b 1200 to 1631 1 to 432       432/442
(97 %)
10 diff
(97.8 %id)
BI760210 pooled colon, kidney, stomach .b 1203 to 1934 1 to 735       735/735
(100 %)
5 diff
(99.4 %id)
TI_57148044   .b 1203 to 1934 35 to 769       735/769
(95 %)
11 diff
(98.6 %id)
CD674555 eye, lens .b 1247 to 1609 1 to 363       363/363
(100 %)
0 diff
(100 %id)
BM791322 stomach .b 1282 to 1908 1 to 627       627/627
(100 %)
0 diff
(100 %id)
DB193629 ovary, tumor tissue .b 1285 to 1858 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BU162748 large cell carcinoma, lung .b 1288 to 2143 5 to 863       857/864
(99 %)
21 diff
(97.6 %id)
BM839574 Ascites, stomach .b 1297 to 1619 1 to 323       323/323
(100 %)
0 diff
(100 %id)
AA132554 colon, tumor .b 2661 to 3109 451 to 3       449/451
(99 %)
0 diff
(100 %id)
CR592301 HeLa cells Cot 25-normalized .c 1 to 1693 1 to 1693 exact tiling clone,   1693/1693
(100 %)
0 diff
(100 %id)
DA425573 colon .c 8 to 588 2 to 584   capped   583/583
(100 %)
5 diff
(99.2 %id)
BQ225866 large cell carcinoma, lung .c 12 to 860 1 to 861       857/897
(95 %)
23 diff
(97.5 %id)
AL555249 placenta .c 15 to 599 18 to 602       585/602
(97 %)
6 diff
(99.1 %id)
TI_45235953   .c 37 to 476 63 to 503       441/505
(87 %)
8 diff
(98.5 %id)
BM722448 eye, fetal eye .c 38 to 756 1 to 720     Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 720/720
(100 %)
2 diff
(99.8 %id)
BX281576 pooled colon, kidney, stomach .c 40 to 531 1 to 492       492/492
(100 %)
2 diff
(99.6 %id)
BC033527 Colon, Kidney, Stomach, adult, whole pooled .c 40 to 1723 1 to 1684 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1684/1684
(100 %)
2 diff
(99.9 %id)
BI517565 pooled colon, kidney, stomach .c 40 to 476 1 to 438   available from MGC,   438/440
(99 %)
3 diff
(99.4 %id)
BM751897 Ascites, stomach .c 41 to 643 1 to 603       603/603
(100 %)
3 diff
(99.6 %id)
BM825339 Ascites, stomach .c 68 to 689 1 to 623       623/623
(100 %)
9 diff
(98.6 %id)
DB192631 ovary, tumor tissue .c 71 to 642 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
BI334525 cervical carcinoma cell line, cervix .c 88 to 884 1 to 799       799/847
(94 %)
10 diff
(98.9 %id)
TI_45235954   .c 849 to 1670 840 to 11       830/1024
(81 %)
18 diff
(98.3 %id)
BM678968 eye, fetal eye .c 1025 to 1723 716 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 698/698
(100 %)
3 diff
(99.6 %id)
DB037579 testis .d 1 to 559 2 to 560   tiling clone, capped   559/559
(100 %)
0 diff
(100 %id)
DA135247 alzheimer cortex .d 6 to 557 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
AW072302 anaplastic oligodendroglioma, brain .d 54 to 422 369 to 1       369/369
(100 %)
0 diff
(100 %id)
TI_157609191   .d 58 to 422 424 to 60       365/645
(56 %)
0 diff
(100 %id)
AU143452   .d 59 to 896 2 to 835   capped   834/845
(98 %)
7 diff
(99.2 %id)
DB469341 hippocampus .d 63 to 492 1 to 431       431/433
(99 %)
5 diff
(98.9 %id)
BU845023 ovary, teratocarcinoma, cell line .d 73 to 913 1 to 848       848/869
(97 %)
13 diff
(98.6 %id)
AK314462 tongue .d 76 to 1667 1 to 1593 A2R     1593/1593
(100 %)
3 diff
(99.9 %id)
DB446495 testis .d 76 to 522 1 to 447       447/447
(100 %)
1 diff
(99.8 %id)
AK054673   .d 77 to 2009 1 to 1933 V319A available from FLJ,   1933/1933
(100 %)
1 diff
(100.0 %id)
DA425303 colon .d 77 to 639 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA431127 colon .d 77 to 641 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
AI480195 anaplastic oligodendroglioma, brain .d 77 to 404 328 to 1       328/328
(100 %)
0 diff
(100 %id)
NM_006111.2   .d 77 to 2009 1 to 1933 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1933/1933
(100 %)
0 diff
(100 %id)
DA047437   .d 78 to 345 2 to 269   capped   268/268
(100 %)
0 diff
(100 %id)
DA626803 Kidney .d 78 to 640 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA903460   .d 80 to 641 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
AU141523 thyroid gland .d 80 to 751 2 to 673   capped   672/672
(100 %)
0 diff
(100 %id)
TI_157596604   .d 84 to 422 380 to 41       340/998
(34 %)
0 diff
(100 %id)
CB160688 Liver .d 96 to 662 1 to 567       567/567
(100 %)
0 diff
(100 %id)
DA567109 heart .d 100 to 655 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
AI885635 anaplastic oligodendroglioma, brain .d 102 to 422 321 to 1       321/321
(100 %)
0 diff
(100 %id)
BY797168 eye .d 105 to 414 1 to 310       310/310
(100 %)
0 diff
(100 %id)
DA562238 heart .d 115 to 691 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
CN355005 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 118 to 742 1 to 625       625/625
(100 %)
0 diff
(100 %id)
AI310696 2 pooled tumors (clear cell type), Kidney .d 119 to 404 286 to 1       286/286
(100 %)
0 diff
(100 %id)
BM848546 myeloma .d 119 to 593 29 to 503       475/475
(100 %)
0 diff
(100 %id)
DA256412 caudate nucleus .d 122 to 686 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA364050 subthalamic nucleus .d 122 to 681 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
AW025204 Kidney .d 125 to 422 298 to 1       298/298
(100 %)
0 diff
(100 %id)
AI392859 B-cell, chronic lymphotic leukemia .d 136 to 404 269 to 1       269/269
(100 %)
0 diff
(100 %id)
CN354999 embryonic stem cells, cell lines H1, H7, andH9 .d 160 to 861 1 to 701       701/701
(100 %)
1 diff
(99.9 %id)
AI589503 anaplastic oligodendroglioma, brain .d 183 to 391 209 to 1       209/209
(100 %)
0 diff
(100 %id)
BM849171 myeloma .d 291 to 955 1 to 665       665/665
(100 %)
0 diff
(100 %id)
BG682914 brain, neuroblastoma, cell line .d 382 to 1037 1 to 660       660/815
(80 %)
14 diff
(98.3 %id)
BP258016 heart .d 388 to 944 1 to 557       557/557
(100 %)
0 diff
(100 %id)
DB196752 trachea .d 389 to 958 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA426231 colon .d 391 to 952 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB475745 hippocampus .d 398 to 891 1 to 494       494/497
(99 %)
2 diff
(99.6 %id)
DB477801 hippocampus .d 398 to 877 1 to 480       480/480
(100 %)
1 diff
(99.8 %id)
DB476959 hippocampus .d 403 to 909 1 to 506       506/509
(99 %)
7 diff
(98.7 %id)
BP211706 cerebrum .d 408 to 991 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BP253249 Kidney .d 408 to 989 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA605576   .d 408 to 1036 2 to 631   capped   630/633
(99 %)
2 diff
(99.7 %id)
DA893599 skeletal muscle .d 408 to 949 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA065327 cerebellum .d 409 to 974 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA135298 alzheimer cortex .d 409 to 956 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
AU121192 whole embryo, mainly body .d 409 to 1231 2 to 832   capped   831/866
(95 %)
15 diff
(98.3 %id)
DA916882 small intestine .d 409 to 974 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BP196803 adrenal gland .d 411 to 991 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP329013 rectum .d 411 to 990 1 to 580       580/582
(99 %)
1 diff
(99.9 %id)
BQ923113 large cell carcinoma, lung .d 412 to 1351 1 to 942       820/942
(87 %)
12 diff
(98.8 %id)
AI985563 Kidney .d 415 to 505 1 to 91     Submitted on the opposite strand 91/91
(100 %)
0 diff
(100 %id)
BE219495 carcinoid, lung .d 415 to 1076 1 to 662     Submitted on the opposite strand 662/662
(100 %)
4 diff
(99.4 %id)
BF435179 pooled .d 415 to 1097 1 to 683   AAA Submitted on the opposite strand 683/683
(100 %)
0 diff
(100 %id)
BM560092 brain, medulla .d 416 to 1401 14 to 1012       999/1017
(98 %)
21 diff
(98.0 %id)
CF272497 Brain glioblastoma .d 416 to 1301 1 to 888       888/888
(100 %)
3 diff
(99.7 %id)
BU164574 large cell carcinoma, lung .d 421 to 1233 1 to 821       821/844
(97 %)
17 diff
(98.0 %id)
BJ995518 hepatoblastoma .d 425 to 833 7 to 415       409/415
(98 %)
6 diff
(98.6 %id)
BP262840 small intestine .d 425 to 995 1 to 571       571/571
(100 %)
0 diff
(100 %id)
BM795429 stomach .d 425 to 965 1 to 541       541/541
(100 %)
0 diff
(100 %id)
AK225457 small intestine .d 426 to 2009 1 to 1584 S310N AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1584/1584
(100 %)
1 diff
(100.0 %id)
DA036698 breast .d 426 to 949 2 to 525   capped   524/524
(100 %)
0 diff
(100 %id)
DA139982 alzheimer cortex .d 426 to 980 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA189815 amygdala .d 426 to 949 2 to 525   capped   524/524
(100 %)
0 diff
(100 %id)
DA428810 colon .d 426 to 989 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA429791 colon .d 426 to 972 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
D16294 Liver .d 426 to 2009 1 to 1584 A2R A169T     1584/1584
(100 %)
3 diff
(99.9 %id)
DA539965 Liver .d 426 to 1215 2 to 789   capped   788/788
(100 %)
4 diff
(99.5 %id)
DA566335 heart .d 426 to 992 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA642630 Liver .d 426 to 998 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA682052 ovary .d 426 to 943 2 to 519   capped   518/518
(100 %)
0 diff
(100 %id)
AU125294   .d 426 to 1230 2 to 808   capped   807/878
(91 %)
7 diff
(99.3 %id)
DA834995 placenta .d 426 to 937 2 to 513   capped   512/512
(100 %)
0 diff
(100 %id)
DA898943 skeletal muscle .d 426 to 990 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
TI_57217578   .d 431 to 1157 61 to 782       722/783
(92 %)
15 diff
(98.1 %id)
TI_57165168   .d 431 to 1199 23 to 796       774/796
(97 %)
16 diff
(98.0 %id)
BG744432 blood, natural killer cells, cell line .d 432 to 1109 1 to 679       679/685
(99 %)
5 diff
(99.3 %id)
TI_154140551   .d 433 to 674 185 to 426       242/243
(99 %)
1 diff
(99.6 %id)
BG427754 Kidney .d 434 to 1230 1 to 803       803/806
(99 %)
20 diff
(97.6 %id)
BI758758 brain .d 434 to 1305 1 to 876       876/905
(96 %)
15 diff
(98.4 %id)
TI_57216220   .d 434 to 1305 1 to 876       876/905
(96 %)
15 diff
(98.4 %id)
BP198619 adrenal gland .d 435 to 1015 1 to 581       581/581
(100 %)
0 diff
(100 %id)
AU118572 whole embryo, mainly head .d 436 to 1280 2 to 844   capped   843/850
(99 %)
10 diff
(98.9 %id)
DA613807   .d 436 to 1022 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA637626 Liver .d 436 to 1008 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BF203966 muscle, rhabdomyosarcoma .d 438 to 1233 1 to 794       794/982
(80 %)
32 diff
(96.8 %id)
AV697589 hepatocellular carcinoma .d 439 to 845 1 to 405       405/426
(95 %)
44 diff
(89.7 %id)
BG570432 lung .d 439 to 1115 1 to 677       677/678
(99 %)
16 diff
(97.7 %id)
CB149630 Liver .d 440 to 1066 1 to 626       626/626
(100 %)
5 diff
(99.3 %id)
DA562859 heart .d 441 to 1011 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
CB151505 cervix, Uterine .d 442 to 1063 1 to 622       622/622
(100 %)
3 diff
(99.6 %id)
DB477815 hippocampus .d 442 to 923 1 to 482       482/482
(100 %)
4 diff
(99.2 %id)
AI281977 carcinoid, lung .d 443 to 949 1 to 507     Submitted on the opposite strand 507/508
(99 %)
1 diff
(99.9 %id)
BF435252 pooled .d 443 to 1097 1 to 655   AAA Submitted on the opposite strand 655/655
(100 %)
4 diff
(99.4 %id)
BM922955 leukocyte .d 445 to 1476 12 to 1047       1036/1087
(95 %)
27 diff
(97.6 %id)
CX870700 embryonic stem .d 445 to 1278 1 to 834       834/834
(100 %)
0 diff
(100 %id)
ES310417 scalp interfollicular dermis, skin .d 446 to 1149 1 to 700       700/719
(97 %)
13 diff
(98.2 %id)
BQ892315 sympathetic trunk .d 448 to 1233 1 to 789       789/902
(87 %)
7 diff
(99.3 %id)
TI_57174583   .d 448 to 1220 30 to 800       771/800
(96 %)
8 diff
(99.0 %id)
BF434612 fibrotheoma, ovary .d 451 to 917 1 to 467     Submitted on the opposite strand 467/467
(100 %)
0 diff
(100 %id)
BQ056215 lymph, lymphoma, cell line .d 452 to 1233 21 to 807       787/1057
(74 %)
13 diff
(98.8 %id)
BI832737 pooled pancreas and spleen .d 453 to 1083 1 to 627       629/628
(100 %)
7 diff
(98.9 %id)
TI_57162266   .d 453 to 1083 28 to 654       629/655
(96 %)
11 diff
(98.4 %id)
CN354996 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 454 to 981 1 to 528       528/528
(100 %)
0 diff
(100 %id)
BF980852 duodenal adenocarcinoma, cell line, small intestine .d 454 to 1197 1 to 739       739/946
(78 %)
29 diff
(97.0 %id)
BU174338 ductal carcinoma, cell line, Pancreas .d 454 to 1256 1 to 807       807/898
(89 %)
9 diff
(99.0 %id)
BC001918 Lung, small cell carcinoma .d 455 to 2009 1 to 1555 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1555/1555
(100 %)
0 diff
(100 %id)
AW248975 lung, small cell carcinoma .d 455 to 1084 10 to 639     Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 630/639
(98 %)
6 diff
(99.1 %id)
TI_57231715   .d 455 to 1198 31 to 776       744/776
(95 %)
11 diff
(98.6 %id)
TI_57146931   .d 456 to 1182 40 to 765       726/765
(94 %)
10 diff
(98.7 %id)
BQ055230 lymph, lymphoma, cell line .d 457 to 1424 1 to 972       972/1035
(93 %)
14 diff
(98.7 %id)
BQ062322 lymph, lymphoma, cell line .d 457 to 1429 1 to 980       978/1025
(95 %)
21 diff
(98.0 %id)
TI_57239545   .d 457 to 1182 36 to 762       727/762
(95 %)
8 diff
(99.0 %id)
BE793962 lung, small cell carcinoma .d 459 to 1230 1 to 769       769/799
(96 %)
7 diff
(99.2 %id)
BQ642807 lymph, lymphoma, cell line .d 459 to 1355 1 to 900       900/950
(94 %)
6 diff
(99.4 %id)
BE265906 lung, small cell carcinoma .d 460 to 1113 1 to 654       654/679
(96 %)
16 diff
(97.7 %id)
H29768 breast .d 462 to 854 1 to 399     Submitted on the opposite strand 399/399
(100 %)
9 diff
(97.8 %id)
AV653212 corresponding non cancerous liver tissue .d 467 to 1111 1 to 645     Submitted on the opposite strand 645/648
(99 %)
3 diff
(99.6 %id)
TI_1948126117   .d 467 to 1081 123 to 738   fully sequenced,   616/738
(83 %)
8 diff
(99.0 %id)
TI_1948126263   .d 467 to 1045 126 to 706       581/1393
(41 %)
20 diff
(98.6 %id)
TI_1948126423   .d 467 to 1081 120 to 741   fully sequenced,   622/741
(83 %)
6 diff
(99.2 %id)
TI_1948126565   .d 467 to 994 125 to 651   fully sequenced,   527/651
(80 %)
12 diff
(98.2 %id)
CV026010 mixed .d 474 to 1104 1 to 631       631/639
(98 %)
3 diff
(99.6 %id)
BE264857 lung, small cell carcinoma .d 475 to 1103 1 to 624       624/624
(100 %)
7 diff
(98.9 %id)
AA058529 eye, retina .d 482 to 911 1 to 430     Submitted on the opposite strand 430/430
(100 %)
0 diff
(100 %id)
CR602624 T cells (Jurkat cell line) Cot10-normalized .d 488 to 1980 1 to 1493       1493/1493
(100 %)
0 diff
(100 %id)
CR603122 HeLa cells Cot 25-normalized .d 488 to 1980 1 to 1493       1493/1493
(100 %)
0 diff
(100 %id)
CR607062 neuroblastoma .d 488 to 1991 1 to 1504       1504/1504
(100 %)
0 diff
(100 %id)
CR610172 fetal brain .d 488 to 1979 1 to 1492       1492/1492
(100 %)
0 diff
(100 %id)
BX383497   .d 488 to 1257 1 to 770   fully sequenced,   770/770
(100 %)
0 diff
(100 %id)
BX341640   .d 488 to 1257 1 to 770   fully sequenced,   770/770
(100 %)
0 diff
(100 %id)
AA128581 lung, lung carcinoma .d 843 to 1227 1 to 386       386/388
(99 %)
2 diff
(99.5 %id)
CN354991 embryonic stem cells, DMSO-treated H9 cellline .d 952 to 1627 1 to 676       676/676
(100 %)
0 diff
(100 %id)
TI_1948126566   .d 964 to 1666 815 to 111   fully sequenced,   705/815
(86 %)
12 diff
(98.6 %id)
BX332403 Neuroblastoma Cot 25-normalized .d 970 to 1981 1004 to 1       1004/1043
(96 %)
14 diff
(98.7 %id)
BX328670 Placenta Cot 25-normalized .d 1007 to 1992 988 to 1       988/988
(100 %)
24 diff
(97.6 %id)
BM720336 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1009 to 1534 1 to 526   fully sequenced, Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 526/526
(100 %)
0 diff
(100 %id)
BM696357 eye, lens .d 1012 to 1528 1 to 517   fully sequenced, Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 517/517
(100 %)
2 diff
(99.7 %id)
TI_1948126424   .d 1016 to 1666 775 to 121   fully sequenced,   655/775
(84 %)
7 diff
(99.1 %id)
BM548746 duodenal adenocarcinoma, cell line, small intestine .d 1050 to 2015 978 to 4     Submitted on the opposite strand 975/1047
(93 %)
16 diff
(98.5 %id)
TI_1948126118   .d 1050 to 1666 731 to 111   fully sequenced,   621/731
(84 %)
7 diff
(99.1 %id)
TI_1948126264   .d 1056 to 1666 766 to 149       618/1425
(43 %)
16 diff
(98.9 %id)
BP226164   .d 1079 to 1658 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BG180336 adenocarcinoma, cell line, Prostate .d 1091 to 1726 1 to 636       636/636
(100 %)
0 diff
(100 %id)
BG674590 skin .d 1095 to 1973 1 to 884       884/884
(100 %)
21 diff
(97.7 %id)
TI_182940157   .d 1103 to 2009 979 to 78   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 902/984
(91 %)
22 diff
(97.8 %id)
BX351862 Placenta Cot 25-normalized .d 1110 to 2007 901 to 1       901/901
(100 %)
13 diff
(98.6 %id)
BU184232 eye, retinoblastoma .d 1110 to 2010 928 to 27     Submitted on the opposite strand 902/928
(97 %)
8 diff
(99.2 %id)
CB162167 Liver .d 1112 to 1759 1 to 648       648/648
(100 %)
1 diff
(99.9 %id)
BG876983 head_neck .d 1144 to 1716 616 to 44       573/621
(92 %)
4 diff
(99.4 %id)
BQ349474 head_neck .d 1144 to 1716 616 to 44       573/621
(92 %)
4 diff
(99.4 %id)
BX411632 placenta .d 1144 to 1999 868 to 12     Submitted on the opposite strand 857/874
(98 %)
6 diff
(99.4 %id)
DR762662 embryonic stem .d 1164 to 1996 833 to 1     Submitted on the opposite strand 833/833
(100 %)
1 diff
(99.9 %id)
CF265042 Brain glioblastoma .d 1167 to 2009 883 to 29   AAA Submitted on the opposite strand 855/855
(100 %)
15 diff
(98.3 %id)
AA031863 uterus .d 1176 to 1566 1 to 391   fully sequenced,   391/391
(100 %)
0 diff
(100 %id)
BX383496   .d 1196 to 1980 784 to 1   fully sequenced,   784/784
(100 %)
1 diff
(99.9 %id)
BX341639   .d 1196 to 1975 783 to 5   fully sequenced,   779/783
(99 %)
0 diff
(100 %id)
BG683620 brain, neuroblastoma, cell line .d 1215 to 1961 748 to 1       748/748
(100 %)
6 diff
(99.2 %id)
BG745080 blood, natural killer cells, cell line .d 1253 to 1944 708 to 18       691/708
(97 %)
1 diff
(99.9 %id)
BE748762 bone marrow, from acute myelogenous leukemia .d 1266 to 1939 693 to 20       674/693
(97 %)
0 diff
(100 %id)
CX763116 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 1268 to 2009 757 to 26   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 732/766
(95 %)
11 diff
(98.6 %id)
BQ314916 denis_drash .d 1269 to 1926 658 to 9       650/658
(98 %)
11 diff
(98.4 %id)
W61060 senescent fibroblast .d 1281 to 1662 382 to 1     Submitted on the opposite strand 382/382
(100 %)
1 diff
(99.8 %id)
BG876391 denis_drash .d 1292 to 1897 612 to 4       609/612
(99 %)
4 diff
(99.4 %id)
TI_149309955   .d 1292 to 2009 840 to 123   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 718/934
(76 %)
4 diff
(99.6 %id)
CN480734 Aveolar Macrophage, lung .d 1306 to 2009 722 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 704/704
(100 %)
1 diff
(99.9 %id)
BQ447919 Knee, Osteoarthritic Cartilage .d 1318 to 2009 710 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 692/692
(100 %)
2 diff
(99.8 %id)
BG216950   .d 1321 to 1995 685 to 16     Submitted on the opposite strand 670/806
(83 %)
18 diff
(97.8 %id)
BQ328211 leiomios .d 1331 to 1945 616 to 2       615/616
(99 %)
3 diff
(99.6 %id)
CX756723 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 1335 to 2009 699 to 25   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 675/677
(99 %)
5 diff
(99.3 %id)
TI_154023105   .d 1336 to 2009 732 to 59   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 674/675
(99 %)
2 diff
(99.8 %id)
CN355002 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1342 to 2009 705 to 38   AAA Submitted on the opposite strand 668/668
(100 %)
2 diff
(99.8 %id)
CX751882 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 1343 to 2009 695 to 29   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 667/667
(100 %)
0 diff
(100 %id)
CN355003 embryonic stem cells, DMSO-treated H9 cellline .d 1344 to 2010 672 to 6     Submitted on the opposite strand 667/672
(99 %)
0 diff
(100 %id)
CV337646 marrow .d 1348 to 1929 582 to 1     Submitted on the opposite strand 582/582
(100 %)
2 diff
(99.7 %id)
BQ377339 uterus .d 1350 to 1789 436 to 1       436/436
(100 %)
5 diff
(98.9 %id)
BX391303 Placenta Cot 25-normalized .d 1353 to 2009 660 to 1       658/769
(85 %)
34 diff
(95.6 %id)
CX758456 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 1356 to 2009 674 to 27   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 648/803
(80 %)
6 diff
(99.3 %id)
BQ020586 Fibrosarcoma .d 1367 to 2009 661 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 643/643
(100 %)
0 diff
(100 %id)
BQ349787 head_neck .d 1379 to 1860 490 to 8       483/490
(98 %)
0 diff
(100 %id)
TI_154190573   .d 1385 to 2009 50 to 673   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 624/624
(100 %)
6 diff
(99.1 %id)
AW966083   .d 1407 to 2009 603 to 1     Submitted on the opposite strand 603/603
(100 %)
12 diff
(98.1 %id)
BE326704 Kidney .d 1422 to 2009 588 to 1       588/588
(100 %)
0 diff
(100 %id)
BM724862.
matches multiple genes
eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1425 to 2010 18 to 603     Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base), also hits gene chawdee 586/641
(91 %)
5 diff
(99.3 %id)
AU147054 whole embryo, mainly body .d 1431 to 2009 573 to 1       573/575
(99 %)
14 diff
(97.6 %id)
AU145096 whole embryo, mainly head .d 1453 to 2009 553 to 1       553/553
(100 %)
12 diff
(97.9 %id)
DB296191   .d 1456 to 2009 555 to 1       555/555
(100 %)
1 diff
(99.9 %id)
DB318071 Liver .d 1456 to 2009 553 to 1       553/554
(99 %)
13 diff
(97.7 %id)
AU148980   .d 1459 to 2009 553 to 1       553/554
(99 %)
8 diff
(98.6 %id)
CR622129 thymus .d 1464 to 2010 1 to 547       547/547
(100 %)
0 diff
(100 %id)
BX414590 thymus .d 1464 to 2010 1 to 547   fully sequenced,   547/547
(100 %)
1 diff
(99.9 %id)
BE465120 carcinoid, lung .d 1467 to 2008 542 to 1       542/542
(100 %)
0 diff
(100 %id)
AU160539   .d 1467 to 2009 539 to 1       539/542
(99 %)
9 diff
(98.4 %id)
AU159062 thyroid gland .d 1475 to 2009 534 to 1       534/535
(99 %)
7 diff
(98.7 %id)
CA439329 lung, Metastatic Chondrosarcoma .d 1477 to 2009 551 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 533/533
(100 %)
0 diff
(100 %id)
BQ376966 uterus .d 1483 to 1860 382 to 5       378/382
(98 %)
1 diff
(99.8 %id)
TI_153989998   .d 1489 to 2009 611 to 89   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 523/524
(99 %)
3 diff
(99.5 %id)
BU735013 eye, lens .d 1498 to 2009 530 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 512/512
(100 %)
0 diff
(100 %id)
BM678903 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1504 to 2009 522 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 504/504
(100 %)
1 diff
(99.9 %id)
DB545644 hippocampus .d 1508 to 2009 1 to 502     Submitted on the opposite strand 502/502
(100 %)
0 diff
(100 %id)
TI_154025296   .d 1519 to 2009 591 to 101   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 491/781
(62 %)
3 diff
(99.7 %id)
BQ668809 epidermoid carcinoma, cell line, salivary gland .d 1529 to 2009 524 to 44   AAA Submitted on the opposite strand 481/858
(56 %)
0 diff
(100 %id)
AA031697 uterus .d 1536 to 2009 474 to 1   fully sequenced,   474/474
(100 %)
2 diff
(99.6 %id)
BF083008 colon_normal .d 1537 to 1790 255 to 1       255/255
(100 %)
5 diff
(98.1 %id)
AI632625 pooled germ cell tumors .d 1542 to 2009 468 to 1       468/468
(100 %)
0 diff
(100 %id)
BX110454 whole brain .d 1551 to 2009 473 to 15   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 459/459
(100 %)
0 diff
(100 %id)
DB522849 testis .d 1551 to 2009 1 to 459     Submitted on the opposite strand 459/459
(100 %)
1 diff
(99.8 %id)
BX414589 thymus .d 1552 to 1982 432 to 1   fully sequenced,   432/432
(100 %)
2 diff
(99.6 %id)
AA834774 ovary .d 1557 to 2015 458 to 2       457/458
(99 %)
3 diff
(99.4 %id)
DB546406 hippocampus .d 1568 to 2002 1 to 435     Submitted on the opposite strand 435/442
(98 %)
1 diff
(99.8 %id)
AW205957   .d 1569 to 2009 458 to 18   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 441/441
(100 %)
0 diff
(100 %id)
DB546420 hippocampus .d 1570 to 2007 1 to 438     Submitted on the opposite strand 438/440
(99 %)
3 diff
(99.4 %id)
DB544560 hippocampus .d 1574 to 2009 1 to 436     Submitted on the opposite strand 436/436
(100 %)
0 diff
(100 %id)
DB525281 testis .d 1576 to 2009 1 to 434     Submitted on the opposite strand 434/434
(100 %)
4 diff
(99.1 %id)
AA129330 lung, lung carcinoma .d 1577 to 2010 443 to 4       440/449
(97 %)
0 diff
(100 %id)
F30242 pectoral muscle (after mastectomy) .d 1578 to 1955 1 to 378       378/378
(100 %)
0 diff
(100 %id)
DB511708 testis .d 1581 to 2009 1 to 429     Submitted on the opposite strand 429/429
(100 %)
0 diff
(100 %id)
AW337148 adenocarcinoma, Pancreas .d 1588 to 2009 422 to 1       422/422
(100 %)
0 diff
(100 %id)
CX785053 human embryonic stem cells .d 1590 to 2013 455 to 32   AAA Submitted on the opposite strand 424/424
(100 %)
3 diff
(99.3 %id)
AI659936 Prostate .d 1599 to 2009 411 to 1       411/411
(100 %)
0 diff
(100 %id)
BE326667 Kidney .d 1601 to 2009 421 to 13   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 409/409
(100 %)
0 diff
(100 %id)
AI332985 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1607 to 2009 403 to 1       403/403
(100 %)
0 diff
(100 %id)
DB536873 hippocampus .d 1611 to 2009 1 to 399     Submitted on the opposite strand 399/399
(100 %)
1 diff
(99.8 %id)
AI650925 Kidney .d 1626 to 2013 388 to 1   tiling clone,   388/388
(100 %)
0 diff
(100 %id)
CN355004 embryonic stem cells, cell lines H1, H7, andH9 .d 1636 to 2013 388 to 11   AAA Submitted on the opposite strand 378/378
(100 %)
8 diff
(97.9 %id)
AW248532 lung, small cell carcinoma .d 1636 to 2009 384 to 11   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 374/374
(100 %)
0 diff
(100 %id)
AW802577.
matches multiple genes
uterus .d 1640 to 1860 237 to 16     also hits gene chawdee 222/249
(89 %)
0 diff
(100 %id)
AI524808 Kidney .d 1643 to 2010 368 to 1       368/368
(100 %)
0 diff
(100 %id)
AI962198 pooled germ cell tumors .d 1656 to 2009 354 to 1       354/354
(100 %)
0 diff
(100 %id)
BE463831 pooled germ cell tumors .d 1656 to 2009 354 to 1       354/354
(100 %)
0 diff
(100 %id)
BE221712 Kidney .d 1662 to 2009 348 to 1       348/348
(100 %)
0 diff
(100 %id)
AI272109 Kidney .d 1708 to 2009 302 to 1       302/302
(100 %)
0 diff
(100 %id)
AW052130 Kidney .d 1718 to 2010 293 to 1       293/293
(100 %)
0 diff
(100 %id)
CN276928 embryonic stem cells, DMSO-treated H9 cellline .d 1720 to 2009 300 to 11   AAA Submitted on the opposite strand 290/290
(100 %)
7 diff
(97.6 %id)
AW608990 pnet .d 1766 to 1874 185 to 77       109/136
(80 %)
0 diff
(100 %id)
AA587251 larynx .d 1799 to 2008 210 to 1       210/210
(100 %)
0 diff
(100 %id)
AW149318 Kidney, renal cell tumor .d 1816 to 2010 195 to 1       195/195
(100 %)
0 diff
(100 %id)
GD154340   .d 1838 to 2015 1 to 181       181/188
(96 %)
8 diff
(95.8 %id)
GD154512   .d 1838 to 2015 1 to 178       178/187
(95 %)
4 diff
(97.9 %id)
DB457378 testis .e 1 to 472 1 to 472   tiling clone,   472/472
(100 %)
1 diff
(99.8 %id)
BG723438 testis .e 12 to 698 1 to 687       687/697
(98 %)
6 diff
(99.2 %id)
DA140860 alzheimer cortex .e 18 to 658 2 to 642   capped   641/641
(100 %)
0 diff
(100 %id)
DB459837 testis .e 20 to 464 1 to 445       445/445
(100 %)
0 diff
(100 %id)
TI_45379493   .e 30 to 762 64 to 813       750/813
(92 %)
53 diff
(93.5 %id)
BX361819   .e 31 to 982 1 to 945       945/945
(100 %)
42 diff
(95.6 %id)
BI488754 brain .e 31 to 762 1 to 750       750/750
(100 %)
54 diff
(92.8 %id)
CR599578 Placenta Cot 25-normalized .e 41 to 1627 1 to 1587 exact     1587/1587
(100 %)
0 diff
(100 %id)
BX399606 Placenta Cot 25-normalized .e 41 to 818 1 to 778   fully sequenced,   778/778
(100 %)
4 diff
(99.5 %id)
CN355001 embryonic stem cells, cell lines H1, H7, andH9 .e 57 to 399 1 to 342       342/342
(100 %)
2 diff
(99.5 %id)
DR761656 embryonic stem .e 67 to 883 1 to 817       817/817
(100 %)
0 diff
(100 %id)
DR157162 human embryonic stem cells differentiated toan early endodermal cell type .e 70 to 807 1 to 738       738/738
(100 %)
0 diff
(100 %id)
BP275887 Kidney .e 75 to 548 1 to 474       474/583
(81 %)
9 diff
(98.5 %id)
CR599438 Placenta Cot 25-normalized .e 80 to 1629 1 to 1550 exact     1550/1550
(100 %)
0 diff
(100 %id)
CR626652 Placenta Cot 25-normalized .e 80 to 1657 1 to 1578 exact tiling clone,   1578/1578
(100 %)
0 diff
(100 %id)
BX338076 Placenta Cot 25-normalized .e 80 to 1035 1 to 955   fully sequenced,   955/955
(100 %)
2 diff
(99.8 %id)
BX328671 Placenta Cot 25-normalized .e 80 to 974 1 to 895       895/895
(100 %)
2 diff
(99.8 %id)
CB116741 Liver .e 88 to 508 1 to 420       420/420
(100 %)
1 diff
(99.8 %id)
BQ943576 large cell carcinoma, lung .e 89 to 1005 22 to 937       916/955
(95 %)
27 diff
(97.2 %id)
BQ935890 large cell carcinoma, lung .e 90 to 1005 21 to 936       914/959
(95 %)
36 diff
(96.3 %id)
BG330607 large cell carcinoma, lung .e 91 to 855 1 to 763       763/788
(96 %)
23 diff
(97.1 %id)
BG332412 large cell carcinoma, lung .e 91 to 822 1 to 723       725/921
(78 %)
31 diff
(96.7 %id)
BE277200 melanotic melanoma, skin .e 132 to 878 1 to 735       736/787
(93 %)
27 diff
(96.6 %id)
BX425027 placenta .e 138 to 1077 3 to 937       937/1046
(89 %)
9 diff
(99.2 %id)
BP296963   .e 148 to 726 1 to 579       579/579
(100 %)
0 diff
(100 %id)
CB154100 Liver .e 155 to 617 1 to 463       463/463
(100 %)
0 diff
(100 %id)
CB161917 Liver .e 155 to 615 1 to 461       461/461
(100 %)
0 diff
(100 %id)
AA773811 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 158 to 749 593 to 1     Submitted on the opposite strand 593/593
(100 %)
7 diff
(98.9 %id)
CN354997 embryonic stem cells, DMSO-treated H9 cellline .e 161 to 590 1 to 430       430/430
(100 %)
0 diff
(100 %id)
TI_154188560   .e 165 to 878 122 to 832       711/946
(75 %)
10 diff
(99.0 %id)
BQ948187 eye, normal pigmented retinal epithelium .e 183 to 1003 1 to 825       825/936
(88 %)
8 diff
(99.2 %id)
BE267474 lung, small cell carcinoma .e 230 to 876 25 to 668       644/676
(95 %)
10 diff
(98.6 %id)
BQ314614 denis_drash .e 332 to 749 434 to 19       416/434
(95 %)
2 diff
(99.6 %id)
BG500189 adenocarcinoma, Prostate .e 341 to 743 1 to 402   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 402/427
(94 %)
4 diff
(99.1 %id)
BQ231316 embryonal carcinoma, cell line, testis .e 352 to 1223 1 to 879       879/879
(100 %)
9 diff
(99.0 %id)
BI261710 lymph, lymphoma, cell line .e 363 to 955 1 to 593   fully sequenced,   593/593
(100 %)
2 diff
(99.7 %id)
BQ062542 lymph, lymphoma, cell line .e 363 to 1182 1 to 832       832/1089
(76 %)
29 diff
(97.4 %id)
BM909616 lymph, lymphoma, cell line .e 364 to 1229 25 to 900       876/1039
(84 %)
24 diff
(97.7 %id)
BQ060078 lymph, lymphoma, cell line .e 364 to 1179 33 to 855       823/1055
(78 %)
16 diff
(98.5 %id)
BQ642724 lymph, lymphoma, cell line .e 364 to 1231 13 to 886       874/951
(91 %)
19 diff
(98.1 %id)
BQ054690 lymph, lymphoma, cell line .e 365 to 1179 1 to 825       825/1016
(81 %)
13 diff
(98.8 %id)
BQ055387 lymph, lymphoma, cell line .e 365 to 1229 1 to 867       867/1004
(86 %)
11 diff
(99.0 %id)
BQ056245 lymph, lymphoma, cell line .e 365 to 1231 1 to 879       879/1026
(85 %)
36 diff
(96.5 %id)
BQ058046 lymph, lymphoma, cell line .e 365 to 1334 1 to 979       977/979
(99 %)
20 diff
(98.0 %id)
BQ058880 lymph, lymphoma, cell line .e 365 to 1325 1 to 963       963/1037
(92 %)
15 diff
(98.6 %id)
BQ059237 lymph, lymphoma, cell line .e 365 to 1229 1 to 873       873/1026
(85 %)
23 diff
(97.8 %id)
BQ061062 lymph, lymphoma, cell line .e 365 to 1330 1 to 982       982/1029
(95 %)
32 diff
(96.9 %id)
BQ063086 lymph, lymphoma, cell line .e 365 to 1289 1 to 929       929/1011
(91 %)
10 diff
(99.1 %id)
BQ063838 lymph, lymphoma, cell line .e 365 to 1229 1 to 875       875/1097
(79 %)
25 diff
(97.8 %id)
BQ064067 lymph, lymphoma, cell line .e 365 to 1229 1 to 872       872/1037
(84 %)
14 diff
(98.7 %id)
BU147115 lymph, lymphoma, cell line .e 365 to 1229 1 to 874       874/931
(93 %)
16 diff
(98.3 %id)
BQ643337 lymph, lymphoma, cell line .e 365 to 1231 1 to 875       875/935
(93 %)
9 diff
(99.1 %id)
BE792113 lung, small cell carcinoma .e 378 to 1211 1 to 844       844/927
(91 %)
23 diff
(97.6 %id)
BF724595 eye, Iris .e 381 to 824 1 to 444       444/444
(100 %)
0 diff
(100 %id)
BQ890068 brain, neuroblastoma, cell line .e 396 to 1231 1 to 834       834/911
(91 %)
15 diff
(98.4 %id)
BQ957005 carcinoma, cell line, Prostate .e 396 to 1305 1 to 908       908/909
(99 %)
8 diff
(99.2 %id)
BU543091 carcinoma, cell line, Prostate .e 396 to 1280 1 to 887       887/890
(99 %)
10 diff
(98.9 %id)
BQ436795 embryonal carcinoma, cell line, testis .e 407 to 1231 1 to 836       836/849
(98 %)
27 diff
(96.9 %id)
BQ934479 large cell carcinoma, lung .e 432 to 1343 15 to 935       922/935
(98 %)
34 diff
(96.4 %id)
BP316289 pericardium .e 438 to 1020 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BU194274 melanotic melanoma, skin .e 447 to 1305 1 to 862       862/870
(99 %)
8 diff
(99.1 %id)
AA366465 Pancreas .e 461 to 766 1 to 306       306/306
(100 %)
0 diff
(100 %id)
BG696266 skin .e 518 to 1354 1 to 839       839/839
(100 %)
4 diff
(99.6 %id)
BG742061 skin .e 529 to 1382 1 to 858       858/858
(100 %)
4 diff
(99.6 %id)
CV575083 cornea, eye .e 533 to 1158 1 to 626       626/626
(100 %)
0 diff
(100 %id)
BG740805 skin .e 538 to 1340 1 to 799       799/799
(100 %)
7 diff
(99.2 %id)
BM789850 stomach .e 573 to 1226 1 to 654       654/654
(100 %)
0 diff
(100 %id)
AI915899 Kidney .e 585 to 744 160 to 1       160/160
(100 %)
0 diff
(100 %id)
H29767 breast .e 751 to 1191 445 to 1     Submitted on the opposite strand 445/446
(99 %)
7 diff
(98.5 %id)
BX382362 Placenta Cot 25-normalized .e 788 to 1627 833 to 1   fully sequenced,   833/833
(100 %)
3 diff
(99.7 %id)
BQ377342 uterus .e 838 to 1232 410 to 17       394/410
(96 %)
1 diff
(99.8 %id)
AF006747   .e 856 to 1085 1 to 230       230/230
(100 %)
0 diff
(100 %id)
H93354 placenta .e 904 to 1121 1 to 220       220/220
(100 %)
8 diff
(96.4 %id)
BI262247 lymph, lymphoma, cell line .e 925 to 1608 685 to 1   fully sequenced,   685/685
(100 %)
6 diff
(99.2 %id)
BX338075 Placenta Cot 25-normalized .e 974 to 1629 656 to 1   fully sequenced,   656/656
(100 %)
0 diff
(100 %id)
AA470517   .e 1429 to 1815 1 to 387   tiling clone,   387/387
(100 %)
7 diff
(98.2 %id)
AA470563   .e 1510 to 1953 449 to 6       444/449
(98 %)
0 diff
(100 %id)
AA420834   .e 1607 to 1953 352 to 6       347/352
(98 %)
0 diff
(100 %id)
CR740736   .e 1655 to 1960 320 to 15   tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 306/306
(100 %)
1 diff
(99.7 %id)
H38582 eye, retina .e 1719 to 1963 254 to 2   tiling clone, Submitted on the opposite strand 253/257
(98 %)
0 diff
(100 %id)
DA537534 Kidney .f 1 to 537 2 to 538   tiling clone, capped   537/537
(100 %)
0 diff
(100 %id)
BE733419 choriocarcinoma, placenta .f 319 to 1087 1 to 761   tiling clone,   763/965
(79 %)
21 diff
(97.9 %id)
BQ054891 lymph, lymphoma, cell line .f 378 to 1080 1 to 706   tiling clone,   706/1041
(67 %)
23 diff
(97.8 %id)
DA539321 Kidney .g 1 to 596 2 to 597   tiling clone, capped   596/596
(100 %)
0 diff
(100 %id)
BG709561 brain, hypothalamus .g 11 to 788 1 to 896       777/973
(79 %)
39 diff
(96.0 %id)
AW977866   .g 27 to 638 7 to 619       613/620
(98 %)
15 diff
(97.6 %id)
TI_57178486   .g 60 to 945 30 to 917 C52V V53L E55K A56L E57K ...     888/951
(93 %)
28 diff
(97.1 %id)
BI769134 pooled lung and spleen .g 65 to 945 1 to 883 C52V V53L E55K A56L E57K ... tiling clone,   883/917
(96 %)
24 diff
(97.4 %id)
AA812035 germinal center B cell .g 68 to 502 1 to 434     Submitted on the opposite strand 434/434
(100 %)
9 diff
(98.0 %id)
CD687367 normal nasopharynx .g 112 to 745 27 to 660   tiling clone,   634/660
(96 %)
7 diff
(99.0 %id)
AA384254 thyroid gland .g 137 to 417 1 to 281       281/281
(100 %)
0 diff
(100 %id)
CN354994 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 253 to 538 1 to 286       286/286
(100 %)
1 diff
(99.7 %id)
DA750600   .h 1 to 559 2 to 560 exact tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
BG431659 Kidney .i 1 to 709 9 to 713       713/713
(100 %)
24 diff
(96.7 %id)
BI562650 testis .i 1 to 763 7 to 777       775/887
(87 %)
23 diff
(97.5 %id)
CB993971 placenta, pre-eclamptic placenta .i 1 to 740 29 to 771   tiling clone,   748/833
(89 %)
15 diff
(98.2 %id)
BP196779 adrenal gland .i 1 to 581 2 to 582       582/582
(100 %)
0 diff
(100 %id)
TI_44351066   .i 1 to 763 134 to 904       770/1014
(75 %)
25 diff
(97.6 %id)
CN354998 embryonic stem cells, cell lines H1, H7, andH9 .i 27 to 593 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
BE208638 lung, small cell carcinoma .i 68 to 713 1 to 643       643/651
(98 %)
20 diff
(97.0 %id)
BP383322 ilea mucosa .i 80 to 546 1 to 466       466/469
(99 %)
5 diff
(99.0 %id)
DA629681 Kidney .i 87 to 659 2 to 577   capped   576/576
(100 %)
5 diff
(99.2 %id)
BE892350 melanotic melanoma, skin .i 88 to 829 1 to 732   tiling clone,   735/885
(83 %)
31 diff
(96.5 %id)
BE791170 lung, small cell carcinoma .i 91 to 829 1 to 735   tiling clone,   735/977
(75 %)
14 diff
(98.6 %id)
BE795064 lung, small cell carcinoma .i 150 to 868 1 to 721 T155N K156Q Q160P T161D E166G ... tiling clone,   721/722
(99 %)
9 diff
(98.8 %id)
AW991398 breast_normal .j 1 to 661 1 to 660 K2R Q3T N9T A10Q V11*     660/660
(100 %)
14 diff
(97.9 %id)
AW991420 breast_normal .j 3 to 734 34 to 763   tiling clone,   730/766
(95 %)
16 diff
(98.0 %id)
BE813157 breast_normal .j 3 to 707 13 to 711   tiling clone,   699/757
(92 %)
17 diff
(97.8 %id)
BE813135 breast_normal .j 5 to 673 1 to 669       669/669
(100 %)
16 diff
(97.7 %id)
AW369482 breast_normal .j 12 to 662 1 to 649   tiling clone,   649/649
(100 %)
13 diff
(98.0 %id)
BQ310764 breast_normal .j 244 to 827 583 to 2       582/589
(98 %)
8 diff
(98.7 %id)
BQ311053 breast_normal .j 258 to 922 664 to 1       664/664
(100 %)
5 diff
(99.3 %id)
BG874314 breast_normal .j 264 to 925 674 to 13       660/677
(97 %)
11 diff
(98.4 %id)
BQ310765 breast_normal .j 264 to 925 668 to 7       662/676
(97 %)
10 diff
(98.6 %id)
BQ311251 breast_normal .j 284 to 925 645 to 10   tiling clone,   636/667
(95 %)
12 diff
(98.3 %id)
BQ311253 breast_normal .j 332 to 869 541 to 1       541/541
(100 %)
11 diff
(98.0 %id)
AW991591 breast_normal .j 416 to 783 1 to 367       367/367
(100 %)
12 diff
(96.8 %id)
BF432185 pooled .j 549 to 808 1 to 260     Submitted on the opposite strand 260/492
(52 %)
4 diff
(99.2 %id)
BQ310621 breast_normal .j 554 to 919 366 to 1   tiling clone,   366/366
(100 %)
4 diff
(99.0 %id)
DA165132 amygdala .k 1 to 560 2 to 561 exact tiling clone, capped   560/561
(99 %)
2 diff
(99.7 %id)
AK092405 placenta .l-u 1 to 2359 2 to 2360 G51V tiling clone, available from FLJ,   2360/2360
(100 %)
3 diff
(99.9 %id)
AX747527   .l-u 1 to 2359 2 to 2360 G51V     2360/2360
(100 %)
3 diff
(99.9 %id)
DA839106 placenta .l-u 1 to 556 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
CV367694 colon_normal .l-u 645 to 879 4 to 235       232/235
(98 %)
6 diff
(97.5 %id)
CV367699 colon_normal .l-u 652 to 932 1 to 280       280/319
(87 %)
21 diff
(93.5 %id)
DB328352 placenta .l-u 1982 to 2359 378 to 1       378/378
(100 %)
1 diff
(99.8 %id)
AW467166 2 pooled tumors (clear cell type), Kidney .m 1 to 681 685 to 5 E4D W5V L6S R9K N10I ... tiling clone,   681/715
(95 %)
30 diff
(95.9 %id)
DB086120 testis .n 1 to 561 2 to 562 exact tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
DW447608 Liver .o 1 to 196 17 to 212 exact tiling clone,   196/212
(92 %)
6 diff
(97.2 %id)
DB141412 thymus .p 1 to 504 2 to 505   tiling clone, capped   504/504
(100 %)
2 diff
(99.7 %id)
DA498008 brain .p 97 to 564 2 to 469   capped   468/468
(100 %)
2 diff
(99.6 %id)
DA952079 Spleen .p 376 to 948 2 to 577   tiling clone, capped   576/576
(100 %)
3 diff
(99.5 %id)
AK093311 testis .p 662 to 2511 1 to 1850 exact tiling clone, available from FLJ,   1850/1850
(100 %)
1 diff
(100.0 %id)
DB030775 testis .p 663 to 1241 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
CX165744 human embryonic stem cells differentiated toan early endodermal cell type .p 1042 to 1858 1 to 817   tiling clone,   817/817
(100 %)
0 diff
(100 %id)
BG926132 cartilage .p 1593 to 2132 86 to 623       538/555
(96 %)
6 diff
(99.0 %id)
DB337010 testis .p 1965 to 2511 550 to 1 exact     550/550
(100 %)
3 diff
(99.5 %id)
DB315733 brain .p 1982 to 2511 534 to 1 exact     534/535
(99 %)
4 diff
(99.3 %id)
DB069807 testis .q-u 1 to 547 2 to 549 exact tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
DC396527 testis .r 1 to 508 1 to 508 D43H T45E tiling clone,   508/578
(87 %)
5 diff
(99.2 %id)
CV416237 placenta_normal .s-u 1 to 463 1 to 467 F4S R5G Y7H Q9P I11M ... tiling clone,   467/467
(100 %)
38 diff
(91.9 %id)
AK093149 testis Gene MYO5BandACAA2, variant not shown       available from FLJ, This clone was ignored    
AK301976 testis Gene MYO5BandACAA2, variant not shown         Suspected internal deletion, this clone was ignored    
AX747955   Gene MYO5BandACAA2, variant not shown         This clone was ignored    
AY274809   Gene MYO5BandACAA2, variant not shown         This clone was ignored    
BQ310661 breast_normal Gene MYO5BandACAA2, variant not shown         Suspected internal deletion, this clone was ignored    
AA253385 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene MYO5BandACAA2, variant not shown         This clone was ignored    
AA253411 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene MYO5BandACAA2, variant not shown         This clone was ignored    
TI_45209941   Gene MYO5BandACAA2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n, .o, .p, .q-u, .r, .s-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI